Targeting Proteins—in-Silico, In-Vitro, and In-Vivo Evidence
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 2683
Special Issue Editors
2. Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria
Interests: protein analysis; drug discovery; in silico evaluation; in vitro and in vivo analysis
Special Issues, Collections and Topics in MDPI journals
2. ScienceConsult - DI Thomas Mohr KG, Enzianweg 10a, 2353 Guntramsdorf, Austria
Interests: bioinformatics; systems biology; cancer; biomarker identification; network analysis; omics analysis; in-vitro test development; data integration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Targeting cellular proteins is critical in order to change the behavior of cells. Recent scientific advances, especially in the field of high-throughput proteomics and molecular simulations, have enabled us to delve deeper into the field of protein interactions; this is of significant importance for gaining novel insights into biological processes and finding previously unknown potential drug targets.
In this Special Issue of Biomedicines, we are interested in original research on the targeting of proteins, especially regarding their druggability, whether this be in silico, in vitro or in vivo. This Special Issue will focus on manuscripts that link the wet lab and the dry lab. However, papers will be considered case-by-case, based on their overall merit.
Dr. Alexander Tolios
Dr. Thomas Mohr
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein analysis
- drug discovery
- in silico evaluation
- in vitro and in vivo analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.